Compare Daicel Corp. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 9.84%
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.84%
4
Flat results in Dec 25
5
With ROCE of 10.60%, it has a very attractive valuation with a 0.95 Enterprise value to Capital Employed
6
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
JPY 397,611 Million (Mid Cap)
6.00
NA
0.00%
0.59
11.36%
1.05
Revenue and Profits:
Net Sales:
147,705 Million
(Quarterly Results - Dec 2025)
Net Profit:
17,304 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.33%
0%
-5.33%
6 Months
-3.79%
0%
-3.79%
1 Year
-1.88%
0%
-1.88%
2 Years
-12.16%
0%
-12.16%
3 Years
37.37%
0%
37.37%
4 Years
56.95%
0%
56.95%
5 Years
56.76%
0%
56.76%
Daicel Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.28%
EBIT Growth (5y)
15.53%
EBIT to Interest (avg)
31.69
Debt to EBITDA (avg)
2.55
Net Debt to Equity (avg)
0.60
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.93%
Dividend Payout Ratio
33.07%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.84%
ROE (avg)
13.94%
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.92
EV to EBIT
8.98
EV to EBITDA
5.35
EV to Capital Employed
0.95
EV to Sales
0.93
PEG Ratio
NA
Dividend Yield
0.04%
ROCE (Latest)
10.60%
ROE (Latest)
15.43%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2020
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
147,705.00
137,849.00
7.15%
Operating Profit (PBDIT) excl Other Income
23,408.00
17,726.00
32.05%
Interest
796.00
781.00
1.92%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17,304.00
9,254.00
86.99%
Operating Profit Margin (Excl OI)
83.40%
51.30%
3.21%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 7.15% vs -1.02% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 86.99% vs -6.73% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
586,531.00
558,056.00
5.10%
Operating Profit (PBDIT) excl Other Income
102,384.00
96,096.00
6.54%
Interest
1,983.00
1,668.00
18.88%
Exceptional Items
-8,385.00
-2,174.00
-285.69%
Consolidate Net Profit
50,477.00
56,545.00
-10.73%
Operating Profit Margin (Excl OI)
104.00%
111.80%
-0.78%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 5.10% vs 3.72% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -10.73% vs 35.79% in Mar 2024
About Daicel Corp. 
Daicel Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






